Recombinant Human VEGF183 Protein (aa 1-209) (VAng-Cr4053)
Recombinant Human VEGF183 Protein (Met1-Arg209) was expressed in Baculovirus-Insect Cells, with a molecular weight of 21 kDa. (Accession ID: P15692-3)
Datasheet
Specifications
Source
Human
Target
VEGF183
Type
Tumor Antigens
Applications
ELISA.
Formulation
Lyophilized from sterile 100 mM Glycine, 10 mM NaCl, pH 7.0.
Purity
> 95% pure by SDS-PAGE.
Storage
Store at -20°C to -80°C.
Antigen Information
Introduction
VEGF is a signal protein produced by cells that stimulates the formation of blood vessels. To be specific, VEGF is a sub-family of growth factors, the platelet-derived growth factor family of cystine-knot growth factors. They are important signaling proteins involved in both vasculogenesis and angiogenesis. It is part of the system that restores the oxygen supply to tissues when blood circulation is inadequate such as in hypoxic conditions. Serum concentration of VEGF is high in bronchial asthma and diabetes mellitus. VEGF's normal function is to create new blood vessels during embryonic development, new blood vessels after injury, muscle following exercise, and new vessels (collateral circulation) to bypass blocked vessels.
Alternative Names
Vascular endothelial growth factor
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
